LeMaitre to Present at the Bank of America Healthcare Conference
LeMaitre Vascular (Nasdaq: LMAT) will present at the Bank of America Healthcare Conference on Wednesday, May 13, 2026 at 5:15 PM PT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
LeMaitre Vascular (Nasdaq: LMAT) will present at the Bank of America Healthcare Conference on Wednesday, May 13, 2026 at 5:15 PM PT. Management presentation details and timing are provided for investors and analysts ahead of the event.
Details
News Market Reaction – LMAT
On May 8, the first trading day after this news, LMAT closed 0.03% above the previous close.
Data tracked by StockTitan Argus for the May 8 session.
Key Figures
- Q1 2026 net sales
- $66.6 million
- Reported in 10-Q for first quarter 2026
- Q1 2026 gross margin
- 72.7%
- Improved gross margin in 10-Q
- Q1 2026 net income
- $15.7 million
- Net income growth vs. prior year quarter
- Q1 2026 diluted EPS
- $0.68
- Diluted EPS reported in 10-Q
- Q1 2026 operating cash flow
- $15.1 million
- Operating cash flow from 10-Q
- Short-term marketable securities
- $340.4 million
- Balance at quarter end in 10-Q
- Convertible senior notes
- $172.5 million
- 2.50% notes due 2030 from 10-Q
- Quarterly dividend
- $0.25 per share
- Dividend level described in 10-Q/8-K
Historical Context
-
Reported Q1 2026 sales, margin, earnings growth and capital return plans.
-
Announced timing and access details for Q1 2026 earnings release.
-
Disclosed management presentation at Needham Virtual Healthcare Conference.
-
Outlined participation in five March 2026 investor conferences and meetings.
-
Reported strong Q4 2025 growth, higher margins, and raised capital returns.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that management will present at the Bank of America Healthcare Conference on Wednesday, May 13, 2026, at 5:15 PM PT.
About LeMaitre
LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
Contact: Sandra Millar LeMaitre Vascular, Inc. +1-781-425-1686 smillar@lemaitre.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.